Home » Thyroid » Priority Review for Alkermes Drug

Priority Review for Alkermes Drug

Priority Review for Alkermes Drug
Recently, Alkermes announced that the US FDA will review the supplemental New Drug Application for Vivitrol for treating pioid dependence on a priority basis.

Read more on Zacks.com via Yahoo! Finance

Tags: , , , ,

Related posts:

  1. New drug effective against aggressive thyroid cancer
  2. New Thyroid Cancer Drug
  3. What thyroid conditions is the drug Armour prescribed for?
  4. Fantasy baseball: Comeback players of the year
  5. Widely Used Plastics Chemical Linked to Testosterone Boost

Want To Provide Some Feedback?